Fujifilm Cellular Dynamics, Inc.
Part of Fujifilm Holdings America Corp
- UEI
- H1LMMSH2CRJ5
- CAGE
- 474X4
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
Parent
Valhalla, NY
UDAMRNS7L2K8
-
Parent
Valhalla, NY
UDAMRNS7L2K8
- SAM.gov registration date
- Website
- fujifilmcdi.com
- Founded
- 2004
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | -$29,020 |
| FY2025 | -$10,266 |
| FY2024 | $474,109 |
| FY2023 | $792,773 |
Contract vehicles
No active vehicles.
1 expired vehicle
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Similar vendors
About the company
Fujifilm Cellular Dynamics, Inc. is a foreign-owned, for-profit manufacturer specializing in the production of biologically relevant human cells derived from induced pluripotent stem cells (iPSCs). As a subsidiary of Fuji Photo Film Company LIMITED, the company focuses on developing and supplying advanced cellular products for biomedical research, drug development, and toxicology screening. The firm has established itself as a key provider of highly specialized and proprietary cell lines to various U.S. federal government agencies, leveraging its unique capabilities in generating differentiated human cell types with high purity and reproducibility.
The company has consistently been awarded federal contracts primarily from civilian agencies within the Department of Health and Human Services, including the National Institutes of Health (NIH), National Center for Advancing Translational Sciences (NCATS), National Institute on Drug Abuse (NIDA), Food and Drug Administration (FDA), and the U.S. Environmental Protection Agency. These contracts, typically structured as firm-fixed-price purchase orders, involve the supply of diverse induced pluripotent stem cell-derived human cell types such as cardiomyocytes, neurons (dopaminergic, glutamatergic, and GABAergic), astrocytes, hepatocytes, endothelial cells, and macrophages. The contracts, which consistently lack small business set-aside designations, support critical research initiatives including drug development, toxicology screening, antiviral research, and the creation of 3D tissue models. The contract values range from approximately $18,000 to $583,000, reflecting the specialized and high-value nature of Fujifilm Cellular Dynamics' cellular products for advanced biomedical research.
Quick answers
Is Fujifilm Cellular Dynamics, Inc. registered in SAM.gov?
Fujifilm Cellular Dynamics, Inc.'s SAM.gov registration expired on February 4, 2025.
Which contract vehicles does Fujifilm Cellular Dynamics, Inc. hold?
Fujifilm Cellular Dynamics, Inc. holds a place on 1 federal contract vehicle: Gene Insertion - Pluripotent Stem Cells 2012-2017.
How much has Fujifilm Cellular Dynamics, Inc. received in federal contracts?
Federal contracts obligated $1,227,597 to Fujifilm Cellular Dynamics, Inc. in fiscal years 2023 through 2027.
What is Fujifilm Cellular Dynamics, Inc.'s most recent federal award?
Fujifilm Cellular Dynamics, Inc.'s most recent federal contract award is Ipsc-derived astrocyte responses (75N95024P00638), from National Institute on Drug Abuse (NIH), on September 18, 2024.
On GovTribe
See Fujifilm Cellular Dynamics, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors